Contraceptive Effectiveness Trial of Cellulose Sulfate Gel
NCT00255294 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2005-11-18
Summary
This study will evaluate the contraceptive effectiveness of cellulose sulfate vaginal gel in preventing pregnancy when used for 6 months.
Conditions
- Contraception
Interventions
- DRUG
-
Cellulose sulfate vaginal gel
Sponsors & Collaborators
-
CONRAD
lead OTHER
Principal Investigators
-
Christine K Mauck, MD · CONRAD
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-01-31
- Completion
- 2005-10-31
Countries
- United States
Study Locations
More Related Trials
-
Postcoital Testing of the SILCS Diaphragm
NCT00561613 ·Status: COMPLETED ·Phase: PHASE1
-
Cellulose Sulfate and HIV Transmission Among Women
NCT00153777 ·Status: TERMINATED ·Phase: PHASE3
-
A Multicenter, Open-Label, Non-Comparative Study of the Safety and Contraceptive Efficacy of the Woman's Condom
NCT01223313 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of BenZalkonium Chloride Gel as Vaginal Contraceptive: a Multicentric Randomized Controlled Trial
NCT00692952 ·Status: COMPLETED ·Phase: PHASE2
-
Spermicidal Efficacy Of A Vaginal Gel
NCT03833115 ·Status: COMPLETED ·Phase: NA
-
Testing Use of Condoms on Regression of Cervical Intraepithelial Neoplasia
NCT02907333 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Gynecological Acceptability of a Health Care Product
NCT04247022 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women
NCT01490671 ·Status: WITHDRAWN ·Phase: PHASE2
-
Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products
NCT02534779 ·Status: COMPLETED ·Phase: NA
-
A Study of BufferGel in Women
NCT00000927 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women
NCT00136643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women
NCT02875119 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness
NCT02994342 ·Status: COMPLETED ·Phase: NA
-
Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
NCT00262106 ·Status: COMPLETED ·Phase: PHASE3
-
Botswana Study of UC-781 Vaginal Microbicide
NCT00385554 ·Status: WITHDRAWN ·Phase: PHASE1
-
Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women
NCT03196492 ·Status: COMPLETED
-
Trial of SAVVY and HIV in Ghana
NCT00129532 ·Status: UNKNOWN ·Phase: PHASE3
-
BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
NCT00074425 ·Status: COMPLETED ·Phase: PHASE2
-
Performance and Safety Trial of an Innovative Female Condom (Wondaleaf®)
NCT02593214 ·Status: COMPLETED ·Phase: NA
-
Study of UC-781 Vaginal Microbicide
NCT00132444 ·Status: COMPLETED ·Phase: PHASE1
-
FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL
NCT07281404 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Tolerability of Metronidazole Gel 1.3%
NCT02392026 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel
NCT00304642 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308046 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
NCT00441909 ·Status: COMPLETED ·Phase: PHASE1